Military

SEALs test electro-magenetic pain management device

Members of the U.S. Special Forces, specifically the Navy SEALs, have shown positive early results after a two-month, ongoing trial of a chronic pain management device. The devices in the trial, called Oska Pulse, utilizes Pulsed Electromagnetic Field technology as a drug-free complement to physical therapy to help reduce pain and inflammation as a result of injuries in affected military personnel.

The device’s developers, Oska, Inc., DBA Oska Wellness, a San Diego-based consumer health and wellness products company, recently met with senior military personnel and therapists at a local military base to discuss performance results to date.

Read the rest.

You've reached your daily free article limit.

Subscribe and support our veteran writing staff to continue reading.

Get Full Ad-Free Access For Just $0.50/Week

Enjoy unlimited digital access to our Military Culture, Defense, and Foreign Policy coverage content and support a veteran owned business. Already a subscriber?

Members of the U.S. Special Forces, specifically the Navy SEALs, have shown positive early results after a two-month, ongoing trial of a chronic pain management device. The devices in the trial, called Oska Pulse, utilizes Pulsed Electromagnetic Field technology as a drug-free complement to physical therapy to help reduce pain and inflammation as a result of injuries in affected military personnel.

The device’s developers, Oska, Inc., DBA Oska Wellness, a San Diego-based consumer health and wellness products company, recently met with senior military personnel and therapists at a local military base to discuss performance results to date.

Read the rest.

About SOFREP News Team View All Posts

The SOFREP News Team is a collective of professional military journalists. Brandon Tyler Webb is the SOFREP News Team's Editor-in-Chief. Guy D. McCardle is the SOFREP News Team's Managing Editor. Brandon and Guy both manage the SOFREP News Team.

COMMENTS

You must become a subscriber or login to view or post comments on this article.

More from SOFREP

REAL EXPERTS.
REAL NEWS.

Join SOFREP for insider access and analysis.

TRY 14 DAYS FREE

Already a subscriber? Log In